Trupanion (NASDAQ:TRUP) Raised to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Trupanion (NASDAQ:TRUP) from a sell rating to a hold rating in a report released on Friday morning, Zacks.com reports.

According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “

TRUP has been the topic of several other research reports. Guggenheim initiated coverage on shares of Trupanion in a research report on Thursday, May 23rd. They issued a buy rating and a $35.00 price target on the stock. ValuEngine cut shares of Trupanion from a buy rating to a hold rating in a research report on Wednesday, March 6th. BidaskClub raised shares of Trupanion from a buy rating to a strong-buy rating in a research report on Monday, April 1st. Finally, Northland Securities initiated coverage on shares of Trupanion in a research report on Tuesday, May 14th. They issued a buy rating and a $40.00 price target on the stock. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. The stock has an average rating of Buy and a consensus target price of $43.90.

TRUP stock opened at $36.45 on Friday. The company has a market cap of $1.25 billion, a PE ratio of -1,215.00 and a beta of 1.32. The stock’s 50-day moving average is $32.60. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.14. Trupanion has a 1 year low of $22.38 and a 1 year high of $46.70.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings data on Thursday, May 2nd. The financial services provider reported ($0.04) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.03). The company had revenue of $86.98 million for the quarter, compared to the consensus estimate of $85.87 million. Trupanion had a negative return on equity of 0.59% and a negative net margin of 0.23%. Trupanion’s revenue for the quarter was up 24.7% compared to the same quarter last year. During the same period last year, the company earned ($0.05) EPS. As a group, research analysts forecast that Trupanion will post -0.07 EPS for the current year.

In other Trupanion news, CRO Margaret Tooth sold 1,000 shares of Trupanion stock in a transaction that occurred on Thursday, April 18th. The shares were sold at an average price of $33.52, for a total transaction of $33,520.00. Following the transaction, the executive now owns 4,693 shares of the company’s stock, valued at approximately $157,309.36. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Darryl Rawlings sold 4,000 shares of Trupanion stock in a transaction that occurred on Thursday, June 20th. The stock was sold at an average price of $36.48, for a total transaction of $145,920.00. Following the transaction, the insider now directly owns 1,523,120 shares in the company, valued at approximately $55,563,417.60. The disclosure for this sale can be found here. In the last three months, insiders have sold 60,253 shares of company stock worth $1,914,452. Insiders own 13.61% of the company’s stock.

Several institutional investors have recently bought and sold shares of TRUP. Gilder Gagnon Howe & Co. LLC bought a new stake in shares of Trupanion during the 1st quarter worth $5,702,000. Clearbridge Investments LLC lifted its holdings in shares of Trupanion by 38.6% during the 1st quarter. Clearbridge Investments LLC now owns 1,220,505 shares of the financial services provider’s stock worth $39,959,000 after acquiring an additional 339,812 shares during the last quarter. Marshall Wace LLP bought a new stake in shares of Trupanion during the 1st quarter worth $406,000. Altrinsic Global Advisors LLC lifted its holdings in shares of Trupanion by 14.1% during the 1st quarter. Altrinsic Global Advisors LLC now owns 161,450 shares of the financial services provider’s stock worth $5,286,000 after acquiring an additional 20,000 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new stake in shares of Trupanion during the 1st quarter worth $507,000. 97.80% of the stock is currently owned by hedge funds and other institutional investors.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.

Recommended Story: NASDAQ

Get a free copy of the Zacks research report on Trupanion (TRUP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.